- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Zecotek Increases Non-Brokered Private Placement to $4.9 Million due to Strong Demand
Zecotek Photonics (TSXV: ZMS), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that due to strong demand the Company has increased the non-brokered private placement previously announced on December 29, 2017, to 16,333,333 units of the Company to be sold at a price of $0.30 per unit for gross proceeds …
Zecotek Photonics (TSXV: ZMS), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that due to strong demand the Company has increased the non-brokered private placement previously announced on December 29, 2017, to 16,333,333 units of the Company to be sold at a price of $0.30 per unit for gross proceeds of $4,900,000.
As quoted in the press release:
Net proceeds from the funds raised will be used to complete the transfer of technology for the purpose of immediate commercialization, strengthen and maintain patents of the Company’s IP portfolio, and used for purchase order financings and general working capital purposes. Pursuant to the financing, the Company may pay a finder’s fee.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.